Further information coming soon
Saturday 7 April 2018 - 7.30 - 8.30 am (includes breakfast)
Intellis with evolve…. Personalised, future proof chronic pain management
Official launch of Medtronic’s next generation platform, Intellis. Dr Marc Russo will detail first implanter experience within Australia, and outline the products significance within the pain stimulation market. Conversation will also focus upon innovative programming paradigms and the need for versatility; in specific relation to the Intellis platform.
Dr Marc Russo is the Director of the Hunter Pain Clinic, Hamilton Day Surgery, Hunter Clinical Research and Co-Director of the Innervate Pain Management Program in Newcastle NSW Australia. He founded the Hunter Pain Clinic in 1999, Hamilton Day Surgery in 2001, Hunter Specialist Medical Centre 2003, Hunter Clinical Research in 2005. He also founded NAPS (Newcastle Anaesthetic Peri-operative Services).
Dr Russo is the founding member and a past President of the Australian Chapter of the International Neuromodulation Society.
Leading the Way: Transforming Patient Outcomes
Professor Julie Pilitsis MD, PhD is a Professor of Neurosurgery and of Neuroscience at Albany Medical College, Albany, NY, and Chair for the Department of Neuroscience and Experimental Therapeutics. She completed her neurosurgery residency at Wayne State University in Detroit, MI. During that time, she also obtained a PhD in neurophysiology and became active in both basic science and translational research. She went on to complete a fellowship in Functional Neurosurgery at Rush University Medical Center in Chicago, IL, focusing in the neurosurgical treatment of movement disorders. She returned to her alma mater Albany Medical College in 2011, joining the division of neurosurgery as an associate professor of neurosurgery and in the Center for Neuropharmacology and Neurosurgery.
Sunday 8 April 2018 - 7.30 - 8.30 am (includes breakfast)
Breakthroughs for new pain areas
This session will include outcome data from Nevro's Expanding Indications clinical study portfolio and the latest advances in HF10 Mechanism of Action.
Speaker: Jey Subbaroyan, Director of Nevro Clinical Research and Kerry Bradley, Sr. Director, Clinical Science & Research, Nevro